MedPath

A Prospective Longitudinal Study of Health-Related Quality of Life in Men With Clinically Localized Prostate Cancer

Completed
Conditions
Prostate Cancer
Registration Number
NCT00777452
Lead Sponsor
Samsung Medical Center
Brief Summary

to prospectively assess the health-related quality of life (HRQOL) changes during the first year after different treatment modalities for localized prostate cancer.

Detailed Description

Quality of life is of great concern to patients considering treatment options for prostate cancer. Patients with clinically localized prostate cancer treated with active surveillance, radical prostatectomy, external radiotherapy and high intensity focused ultrasound were included. All men completed the questionnaires of Functional Assessment of Cancer Therapy-Prostate (FACT-P) (version 4), International Prostate Symptom Score (IPSS) and International Index of Erectile Function (IIEF) before treatment and 1, 3, 6, 12 months after treatment.

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
93
Inclusion Criteria
  • patients diagnosed with clinically localized prostate cancer
Exclusion Criteria
  • patients with another malignancies

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Health-related quality of life changes over time12 months after treatment
Secondary Outcome Measures
NameTimeMethod
urinary symptom score and erectile function over time12 months after treatment

Trial Locations

Locations (1)

Department of Urology, Samsung Medical Center, Sungkyunkwan University School of Medicine

🇰🇷

Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath